Guidance on the use of post exposure prophylaxis for measles in high risk groups.
Ref: PHE publications gateway number: 2017250 PDF, 350KB, 23 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
This guidance summarises the evidence for the effectiveness of post exposure prophylaxis (PEP) for measles and provides advice on the assessment for PEP for high risk groups, in the following order of priority:
- immunosuppressed individuals
- pregnant women and infants